Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
NCR-National Cancer Registry of The Netherlands (2013) Cancer in the Netherlands – online data registry. Vereniging Integrale Kankercentra, Utrecht. www.cancerregistry.nl
de Vries E, Houterman S, Janssen-Heijnen ML, Nijsten T, van de Schans SA, Eggermont AM, Coebergh JW (2007) Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands. Ann Oncol 18(6):1110–1116
Friedman RJ, Rigel DS, Kopf AW (1985) Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin 35(3):130–151
Abbasi NR, Shaw HM, Rigel DS, Friedman RJ, McCarthy WH, Osman I, Kopf AW, Polsky D (2004) Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA 292(22):2771–2776
Chamberlain AJ, Fritschi L, Kelly JW (2003) Nodular melanoma: patients’ perceptions of presenting features and implications for earlier detection. J Am Acad Dermatol 48(5):694–701
Rofstad EK, Brustad T (1985) Tumour growth delay following single dose irradiation of human melanoma xenografts. Correlations with tumour growth parameters, vascular structure and cellular radiosensitivity. Br J Cancer 51(2):201–210
Bentzen SM, Overgaard J, Thames HD, Overgaard M, Vejby Hansen P, von der Maase H, Meder J (1989) Clinical radiobiology of malignant melanoma. Radiother Oncol 16(3):169–182
Bentzen SM, Thames HD, Overgaard J (1990) Does variation in the in vitro cellular radiosensitivity explain the shallow clinical dose-control curve for malignant melanoma? Int J Radiat Biol 57(1):117–126
Sause WT, Cooper JS, Rush S, Ago CT, Cosmatos D, Coughlin CT, JanJan N, Lipsett J (1991) Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 20(3):429–432
Corry J, Smith JG, Bishop M, Ainslie J (1999) Nodal radiation therapy for metastatic melanoma. Int J Radiat Oncol Biol Phys 44(5):1065–1069
Fenig E, Eidelevich E, Njuguna E, Katz A, Gutman H, Sulkes A, Schechter J (1999) Role of radiation therapy in the management of cutaneous malignant melanoma. Am J Clin Oncol 22(2):184–186
Burmeister BH, Mark Smithers B, Burmeister E, Baumann K, Davis S, Krawitz H, Johnson C, Spry N, Trans Tasman Radiation Oncology Group (2006) A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06. Radiother Oncol 81(2):136–142
Chang DT, Amdur RJ, Morris CG, Mendenhall WM (2006) Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation. Int J Radiat Oncol Biol Phys 66(4):1051–1055
Strojan P, Jancar B, Cemazar M, Perme MP, Hocevar M (2010) Melanoma metastases to the neck nodes: role of adjuvant irradiation. Int J Radiat Oncol Biol Phys 77(4):1039–1045
Harwood AR, Cummings BJ (1981) Radiotherapy for malignant melanoma: a re-appraisal. Cancer Treat Rev 8:271–282
Trott KR (1991) The optimal radiation dose per fraction for treatment of malignant melanomas. Int J Radiat Oncol Biol Phys 20:905–907
Gojkovič-Horvat A, Jančar B, Blas M, Zumer B, Karner K, Hočevar M, Strojan P (2012) Adjuvant radiotherapy for palpable melanoma metastases to the groin: when to irradiate? Int J Radiat Oncol Biol Phys 83(1):310–316
Bastiaannet E, Beukema JC, Hoekstra HJ (2005) Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Cancer Treat Rev 31(1):18–26
Seegenschmiedt MH, Keilholz L, Altendorf-Hofmann A, Urban A, Schell H, Hohenberger W, Sauer R (1999) Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience. Int J Radiat Oncol Biol Phys 44(3):607–618
Hulshof MC, Van Haaren PM, Zum Vörde Sive Vörding PJ, Krishnadath S, Marsman WA, Van Berge Henegouwen MI, Geijsen ED, Crezee J (2010) Radiotherapy combined with hyperthermia for primary malignant melanomas of the esophagus. Dis Esophagus 23(8):E42–E47
Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, Bentzen SM (2009) Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. 1996. Int J Hyperthermia 25(5):323–334
Douglas JG, Margolin K (2002) The treatment of brain metastases from malignant melanoma. Semin Oncol 29(5):518–524
Staudt M, Lasithiotakis K, Leiter U, Meier F, Eigentler T, Bamberg M, Tatagiba M, Brossart P, Garbe C (2010) Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer 102(8):1213–1218
Koomen ER, de Vries E, van Kempen LC, van Akkooi AC, Guchelaar HJ, Louwman MW, Nijsten T, Coebergh JW (2010) Epidemiology of extracutaneous melanoma in the Netherlands. Cancer Epidemiol Biomarkers Prev 19(6):1453–1459
Damato B (2006) Treatment of primary intraocular melanoma. Expert Rev Anticancer Ther 6(4):493–506
Diener-West M, Earle JD, Fine SL, Hawkins BS, Moy CS, Reynolds SM, Schachat AP, Straatsma BR, Collaborative Ocular Melanoma Study Group (2001) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 119(7):969–982
Verschueren KM, Creutzberg CL, Schalij-Delfos NE, Ketelaars M, Klijsen FL, Haeseker BI, Ligtenberg SM, Keunen JE, Marijnen CA (2010) Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma. Radiother Oncol 95(3):332–338
Shields CL, Shields JA (2009) Ocular melanoma: relatively rare but requiring respect. Clin Dermatol 27(1):122–133
Damato B, Coupland SE (2009) An audit of conjunctival melanoma treatment in Liverpool. Eye (Lond) 23(4):801–809
Walsh-Conway N, Conway RM (2009) Plaque brachytherapy for the management of ocular surface malignancies with corneoscleral invasion. Clin Experiment Ophthalmol 37(6):577–583
Finger PT (2009) Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects. Surv Ophthalmol 54(5):545–568
Hodi FS, O’Day SJ, McDermott DF et al (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363(8):711–723
Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O’Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JH, de Bono JS (2009) Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361(2):123–134
Krawczyk PM, Eppink B, Essers J, Stap J, Rodermond H, Odijk H, Zelensky A, van Bree C, Stalpers LJ, Buist MR, Soullié T, Rens J, Verhagen HJ, O’Connor MJ, Franken NA, Ten Hagen TL, Kanaar R, Aten JA (2011) Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. Proc Natl Acad Sci U S A 108N:9851–9856
UICC-WHO International Union Against Cancer (2010) TNM Classification of malignant tumours. In: Sobin LH, Gospodarowicz MK, Wittekind C (eds) Melanoma of the skin, 7th edn. Springer, Berlin, pp 172–176
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Stalpers, L.J.A., Hulshof, M.C.C.M. (2015). Cutaneous Melanoma. In: Panizzon, R., Seegenschmiedt, M. (eds) Radiation Treatment and Radiation Reactions in Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44826-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-662-44826-7_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44825-0
Online ISBN: 978-3-662-44826-7
eBook Packages: MedicineMedicine (R0)